MovDisordV3, PascalFrancis, Corpus, bibRecord, 000035

Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies

Identifieur interne : 000035 ( PascalFrancis/Corpus ); précédent : 000034; suivant : 000036

Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies

Auteurs : Hugo Morales-Briceno ; Mayela Rodriguez-Violante ; Amin Cervantes-Arriaga ; Sarosh R. Irani ; Andrew J. Lees ; Laura Silveira-Moriyama

Source :

Movement disorders [ 0885-3185 ] ; 2012.

RBID : Pascal:13-0017936

Descripteurs français

Pascal (Inist)
- Opsoclonie, Myoclonie, Pathologie du système nerveux.

English descriptors

KwdEn :
- Myoclonus, Nervous system diseases, Opsoclonus.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 27`
A06				`@2 13`
A08	`01`	`1`	`ENG`	`@1 Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies`
A11	`01`	`1`		`@1 MORALES-BRICENO (Hugo)`
A11	`02`	`1`		`@1 RODRIGUEZ-VIOLANTE (Mayela)`
A11	`03`	`1`		`@1 CERVANTES-ARRIAGA (Amin)`
A11	`04`	`1`		`@1 IRANI (Sarosh R.)`
A11	`05`	`1`		`@1 LEES (Andrew J.)`
A11	`06`	`1`		`@1 SILVEIRA-MORIYAMA (Laura)`
A14	`01`			`@1 Department of Neurology, Instituto Nacional de Neurología y Neurocirugia @2 Mexico City @3 MEX @Z 1 aut.`
A14	`02`			`@1 Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia @2 Mexico City @3 MEX @Z 2 aut. @Z 3 aut.`
A14	`03`			`@1 Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia @2 Mexico City @3 MEX @Z 2 aut. @Z 3 aut.`
A14	`04`			`@1 Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital @2 Oxford @3 GBR @Z 4 aut.`
A14	`05`			`@1 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology @2 London @3 GBR @Z 5 aut. @Z 6 aut.`
A14	`06`			`@1 Department of Neurology, University of Campinas, UNICAMP @2 Campinas @3 BRA @Z 6 aut.`
A20				`@1 1615-1616`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000505459050090`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 5 ref.`
A47	`01`	`1`		`@0 13-0017936`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17D`
C03	`01`	`X`	`FRE`	`@0 Opsoclonie @5 01`
C03	`01`	`X`	`ENG`	`@0 Opsoclonus @5 01`
C03	`01`	`X`	`SPA`	`@0 Opsoclonación @5 01`
C03	`02`	`X`	`FRE`	`@0 Myoclonie @5 02`
C03	`02`	`X`	`ENG`	`@0 Myoclonus @5 02`
C03	`02`	`X`	`SPA`	`@0 Mioclonia @5 02`
C03	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 03`
C03	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 03`
C03	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 03`
C07	`01`	`X`	`FRE`	`@0 Syndrome oculomoteur @5 37`
C07	`01`	`X`	`ENG`	`@0 Oculomotor syndrome @5 37`
C07	`01`	`X`	`SPA`	`@0 Oculomotricidad síndrome @5 37`
C07	`02`	`X`	`FRE`	`@0 Pathologie de l'oeil @5 38`
C07	`02`	`X`	`ENG`	`@0 Eye disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Ojo patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Mouvement involontaire @5 39`
C07	`03`	`X`	`ENG`	`@0 Involuntary movement @5 39`
C07	`03`	`X`	`SPA`	`@0 Movimiento involuntario @5 39`
C07	`04`	`X`	`FRE`	`@0 Trouble neurologique @5 41`
C07	`04`	`X`	`ENG`	`@0 Neurological disorder @5 41`
C07	`04`	`X`	`SPA`	`@0 Trastorno neurológico @5 41`
N21				`@1 007`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 13-0017936 INIST
ET :	Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies
AU :	MORALES-BRICENO (Hugo); RODRIGUEZ-VIOLANTE (Mayela); CERVANTES-ARRIAGA (Amin); IRANI (Sarosh R.); LEES (Andrew J.); SILVEIRA-MORIYAMA (Laura)
AF :	Department of Neurology, Instituto Nacional de Neurología y Neurocirugia/Mexico City/Mexique (1 aut.); Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia/Mexico City/Mexique (2 aut., 3 aut.); Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia/Mexico City/Mexique (2 aut., 3 aut.); Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital/Oxford/Royaume-Uni (4 aut.); Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology/London/Royaume-Uni (5 aut., 6 aut.); Department of Neurology, University of Campinas, UNICAMP/Campinas/Brésil (6 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2012; Vol. 27; No. 13; Pp. 1615-1616; Bibl. 5 ref.
LA :	Anglais
CC :	002B17; 002B17D
FD :	Opsoclonie; Myoclonie; Pathologie du système nerveux
FG :	Syndrome oculomoteur; Pathologie de l'oeil; Mouvement involontaire; Trouble neurologique
ED :	Opsoclonus; Myoclonus; Nervous system diseases
EG :	Oculomotor syndrome; Eye disease; Involuntary movement; Neurological disorder
SD :	Opsoclonación; Mioclonia; Sistema nervioso patología
LO :	INIST-20953.354000505459050090
ID :	13-0017936

Links to Exploration step

Pascal:13-0017936

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies</title>
<author><name sortKey="Morales Briceno, Hugo" sort="Morales Briceno, Hugo" uniqKey="Morales Briceno H" first="Hugo" last="Morales-Briceno">Hugo Morales-Briceno</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Instituto Nacional de Neurología y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rodriguez Violante, Mayela" sort="Rodriguez Violante, Mayela" uniqKey="Rodriguez Violante M" first="Mayela" last="Rodriguez-Violante">Mayela Rodriguez-Violante</name>
<affiliation><inist:fA14 i1="02"><s1>Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cervantes Arriaga, Amin" sort="Cervantes Arriaga, Amin" uniqKey="Cervantes Arriaga A" first="Amin" last="Cervantes-Arriaga">Amin Cervantes-Arriaga</name>
<affiliation><inist:fA14 i1="02"><s1>Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Irani, Sarosh R" sort="Irani, Sarosh R" uniqKey="Irani S" first="Sarosh R." last="Irani">Sarosh R. Irani</name>
<affiliation><inist:fA14 i1="04"><s1>Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital</s1>
<s2>Oxford</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation><inist:fA14 i1="05"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Silveira Moriyama, Laura" sort="Silveira Moriyama, Laura" uniqKey="Silveira Moriyama L" first="Laura" last="Silveira-Moriyama">Laura Silveira-Moriyama</name>
<affiliation><inist:fA14 i1="05"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurology, University of Campinas, UNICAMP</s1>
<s2>Campinas</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0017936</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 13-0017936 INIST</idno>
<idno type="RBID">Pascal:13-0017936</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000035</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies</title>
<author><name sortKey="Morales Briceno, Hugo" sort="Morales Briceno, Hugo" uniqKey="Morales Briceno H" first="Hugo" last="Morales-Briceno">Hugo Morales-Briceno</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Instituto Nacional de Neurología y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rodriguez Violante, Mayela" sort="Rodriguez Violante, Mayela" uniqKey="Rodriguez Violante M" first="Mayela" last="Rodriguez-Violante">Mayela Rodriguez-Violante</name>
<affiliation><inist:fA14 i1="02"><s1>Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cervantes Arriaga, Amin" sort="Cervantes Arriaga, Amin" uniqKey="Cervantes Arriaga A" first="Amin" last="Cervantes-Arriaga">Amin Cervantes-Arriaga</name>
<affiliation><inist:fA14 i1="02"><s1>Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Irani, Sarosh R" sort="Irani, Sarosh R" uniqKey="Irani S" first="Sarosh R." last="Irani">Sarosh R. Irani</name>
<affiliation><inist:fA14 i1="04"><s1>Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital</s1>
<s2>Oxford</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew J. Lees</name>
<affiliation><inist:fA14 i1="05"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Silveira Moriyama, Laura" sort="Silveira Moriyama, Laura" uniqKey="Silveira Moriyama L" first="Laura" last="Silveira-Moriyama">Laura Silveira-Moriyama</name>
<affiliation><inist:fA14 i1="05"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Department of Neurology, University of Campinas, UNICAMP</s1>
<s2>Campinas</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Myoclonus</term>
<term>Nervous system diseases</term>
<term>Opsoclonus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Opsoclonie</term>
<term>Myoclonie</term>
<term>Pathologie du   système nerveux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>27</s2>
</fA05>
<fA06><s2>13</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MORALES-BRICENO (Hugo)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>RODRIGUEZ-VIOLANTE (Mayela)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CERVANTES-ARRIAGA (Amin)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>IRANI (Sarosh R.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LEES (Andrew J.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>SILVEIRA-MORIYAMA (Laura)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Instituto Nacional de Neurología y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital</s1>
<s2>Oxford</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Neurology, University of Campinas, UNICAMP</s1>
<s2>Campinas</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>1615-1616</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000505459050090</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>5 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0017936</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Opsoclonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Opsoclonus</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Opsoclonación</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Myoclonie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Myoclonus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Mioclonia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Syndrome oculomoteur</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Oculomotor syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Oculomotricidad síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'oeil</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fN21><s1>007</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 13-0017936 INIST</NO>
<ET>Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies</ET>
<AU>MORALES-BRICENO (Hugo); RODRIGUEZ-VIOLANTE (Mayela); CERVANTES-ARRIAGA (Amin); IRANI (Sarosh R.); LEES (Andrew J.); SILVEIRA-MORIYAMA (Laura)</AU>
<AF>Department of Neurology, Instituto Nacional de Neurología y Neurocirugia/Mexico City/Mexique (1 aut.); Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurologia y Neurocirugia/Mexico City/Mexique (2 aut., 3 aut.); Movement Disorders Clinic, Instituto Nacional de Neurologia y Neurocirugia/Mexico City/Mexique (2 aut., 3 aut.); Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital/Oxford/Royaume-Uni (4 aut.); Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology/London/Royaume-Uni (5 aut., 6 aut.); Department of Neurology, University of Campinas, UNICAMP/Campinas/Brésil (6 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2012; Vol. 27; No. 13; Pp. 1615-1616; Bibl. 5 ref.</SO>
<LA>Anglais</LA>
<CC>002B17; 002B17D</CC>
<FD>Opsoclonie; Myoclonie; Pathologie du   système nerveux</FD>
<FG>Syndrome oculomoteur; Pathologie de l'oeil; Mouvement involontaire; Trouble neurologique</FG>
<ED>Opsoclonus; Myoclonus; Nervous system diseases</ED>
<EG>Oculomotor syndrome; Eye disease; Involuntary movement; Neurological disorder</EG>
<SD>Opsoclonación; Mioclonia; Sistema nervioso patología</SD>
<LO>INIST-20953.354000505459050090</LO>
<ID>13-0017936</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000035 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000035 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0017936
   |texte=   Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies

Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri